Literature DB >> 25870278

Hyperammonemia in gene-targeted mice lacking functional hepatic glutamine synthetase.

Natalia Qvartskhava1, Philipp A Lang2, Boris Görg1, Vitaly I Pozdeev1, Marina Pascual Ortiz1, Karl S Lang3, Hans J Bidmon4, Elisabeth Lang1, Christina B Leibrock5, Diran Herebian6, Johannes G Bode1, Florian Lang5, Dieter Häussinger7.   

Abstract

Urea cycle defects and acute or chronic liver failure are linked to systemic hyperammonemia and often result in cerebral dysfunction and encephalopathy. Although an important role of the liver in ammonia metabolism is widely accepted, the role of ammonia metabolizing pathways in the liver for maintenance of whole-body ammonia homeostasis in vivo remains ill-defined. Here, we show by generation of liver-specific Gln synthetase (GS)-deficient mice that GS in the liver is critically involved in systemic ammonia homeostasis in vivo. Hepatic deletion of GS triggered systemic hyperammonemia, which was associated with cerebral oxidative stress as indicated by increased levels of oxidized RNA and enhanced protein Tyr nitration. Liver-specific GS-deficient mice showed increased locomotion, impaired fear memory, and a slightly reduced life span. In conclusion, the present observations highlight the importance of hepatic GS for maintenance of ammonia homeostasis and establish the liver-specific GS KO mouse as a model with which to study effects of chronic hyperammonemia.

Entities:  

Keywords:  RNA oxidation; glutamine; hepatic encephalopathy; metabolic zonation; oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 25870278      PMCID: PMC4418919          DOI: 10.1073/pnas.1423968112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  60 in total

Review 1.  Astrocyte dysfunction in neurological disorders: a molecular perspective.

Authors:  Gerald Seifert; Karl Schilling; Christian Steinhäuser
Journal:  Nat Rev Neurosci       Date:  2006-03       Impact factor: 34.870

2.  Reversible inhibition of mammalian glutamine synthetase by tyrosine nitration.

Authors:  Boris Görg; Natalia Qvartskhava; Peter Voss; Tilman Grune; Dieter Häussinger; Freimut Schliess
Journal:  FEBS Lett       Date:  2006-12-12       Impact factor: 4.124

3.  Portal hypertension in 18-month-old rats: memory deficits and brain metabolic activity.

Authors:  Azucena Begega; Marta Méndez; Sandra Rubio; Luis J Santín; María A Aller; Jaime Arias; Jorge L Arias
Journal:  Physiol Behav       Date:  2010-02-23

4.  Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra.

Authors:  Omar Cauli; Marta Llansola; Slaven Erceg; Vicente Felipo
Journal:  J Hepatol       Date:  2006-08-10       Impact factor: 25.083

5.  Locomotor impairment and cerebrocortical oxidative stress in portal vein ligated rats in vivo.

Authors:  Jonathan Brück; Boris Görg; Hans-Jürgen Bidmon; Irinia Zemtsova; Natalia Qvartskhava; Verena Keitel; Gerald Kircheis; Dieter Häussinger
Journal:  J Hepatol       Date:  2010-09-15       Impact factor: 25.083

Review 6.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 7.  Inflammation and hepatic encephalopathy.

Authors:  Iona Coltart; Thomas H Tranah; Debbie L Shawcross
Journal:  Arch Biochem Biophys       Date:  2013-04-10       Impact factor: 4.013

8.  Hepatocyte heterogeneity in glutamine and ammonia metabolism and the role of an intercellular glutamine cycle during ureogenesis in perfused rat liver.

Authors:  D Häussinger
Journal:  Eur J Biochem       Date:  1983-06-15

Review 9.  The slowed brain: cortical oscillatory activity in hepatic encephalopathy.

Authors:  Markus Butz; Elisabeth S May; Dieter Häussinger; Alfons Schnitzler
Journal:  Arch Biochem Biophys       Date:  2013-04-16       Impact factor: 4.013

10.  Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia.

Authors:  Wenlei Jiang; Paul Desjardins; Roger F Butterworth
Journal:  J Cereb Blood Flow Metab       Date:  2009-03-04       Impact factor: 6.200

View more
  25 in total

1.  Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia.

Authors:  Kiyoshi Hayasaka; Chikahiko Numakura; Mitsunori Yamakawa; Tetsuo Mitsui; Hisayoshi Watanabe; Hiroaki Haga; Masahide Yazaki; Hiromasa Ohira; Yasuo Ochiai; Toshiyuki Tahara; Tamio Nakahara; Noriyo Yamashiki; Takahiro Nakayama; Takashi Kon; Hiroshi Mitsubuchi; Hiroshi Yoshida
Journal:  J Inherit Metab Dis       Date:  2018-04-12       Impact factor: 4.982

2.  Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations.

Authors:  Adeola O Adebayo Michael; Sungjin Ko; Junyan Tao; Akshata Moghe; Hong Yang; Meng Xu; Jacquelyn O Russell; Tirthadipa Pradhan-Sundd; Silvia Liu; Sucha Singh; Minakshi Poddar; Jayvir S Monga; Pin Liu; Michael Oertel; Sarangarajan Ranganathan; Aatur Singhi; Sandra Rebouissou; Jessica Zucman-Rossi; Silvia Ribback; Diego Calvisi; Natalia Qvartskhava; Boris Görg; Dieter Häussinger; Xin Chen; Satdarshan P Monga
Journal:  Cell Metab       Date:  2019-01-31       Impact factor: 27.287

3.  Enhancement of hepatic autophagy increases ureagenesis and protects against hyperammonemia.

Authors:  Leandro R Soria; Gabriella Allegri; Dominique Melck; Nunzia Pastore; Patrizia Annunziata; Debora Paris; Elena Polishchuk; Edoardo Nusco; Beat Thöny; Andrea Motta; Johannes Häberle; Andrea Ballabio; Nicola Brunetti-Pierri
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-26       Impact factor: 11.205

4.  Proximal tubule glutamine synthetase expression is necessary for the normal response to dietary protein restriction.

Authors:  Hyun-Wook Lee; Gunars Osis; Mary E Handlogten; Jill W Verlander; I David Weiner
Journal:  Am J Physiol Renal Physiol       Date:  2017-03-22

5.  Transgenic expression of the human growth hormone minigene promotes pancreatic β-cell proliferation.

Authors:  Mieke Baan; Carly R Kibbe; Justin R Bushkofsky; Ted W Harris; Dawn S Sherman; Dawn Belt Davis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-07-22       Impact factor: 3.619

6.  Taurine transporter (TauT) deficiency impairs ammonia detoxification in mouse liver.

Authors:  Natalia Qvartskhava; Cheng Jun Jin; Tobias Buschmann; Ute Albrecht; Johannes Georg Bode; Niloufar Monhasery; Jessica Oenarto; Hans Jürgen Bidmon; Boris Görg; Dieter Häussinger
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-12       Impact factor: 11.205

7.  Hepatic glutamine synthetase augmentation enhances ammonia detoxification.

Authors:  Leandro R Soria; Matthew Nitzahn; Angela De Angelis; Suhail Khoja; Sergio Attanasio; Patrizia Annunziata; Donna J Palmer; Philip Ng; Gerald S Lipshutz; Nicola Brunetti-Pierri
Journal:  J Inherit Metab Dis       Date:  2019-03-11       Impact factor: 4.982

8.  Ammonia Attenuates LPS-Induced Upregulation of Pro-Inflammatory Cytokine mRNA in Co-Cultured Astrocytes and Microglia.

Authors:  Ayse Karababa; Katerina Groos-Sahr; Ute Albrecht; Verena Keitel; Aygul Shafigullina; Boris Görg; Dieter Häussinger
Journal:  Neurochem Res       Date:  2016-09-21       Impact factor: 3.996

9.  Epithelial splicing regulatory protein 2-mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis.

Authors:  Jeongeun Hyun; Zhaoli Sun; Ali Reza Ahmadi; Sushant Bangru; Ullas V Chembazhi; Kuo Du; Tianyi Chen; Hidekazu Tsukamoto; Ivan Rusyn; Auinash Kalsotra; Anna Mae Diehl
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 10.  Clinical science workshop: targeting the gut-liver-brain axis.

Authors:  Vishal C Patel; Helen White; Sidsel Støy; Jasmohan S Bajaj; Debbie L Shawcross
Journal:  Metab Brain Dis       Date:  2015-10-08       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.